Medicare Enrolled
Dr. Shahid Siddiqui, MD
Optician · San Jose, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Siddiqui from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Siddiqui?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Siddiqui
Dr. Shahid Siddiqui is an optician specialist in San Jose, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Siddiqui performed 9,920 Medicare services across 2,120 unique beneficiaries.
Between the years covered by Open Payments, Dr. Siddiqui received a total of $3,331 from 24 pharmaceutical and/or device companies across 141 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Siddiqui is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 9% volume in CA
$3,331 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,920
Medicare services
Top 9% in CA for optician
2,120
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~496 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Adenosine injection, 1 mg Administration of a 1 mg dose of adenosine medication. This code is specifically for adenosine and excludes adenosine phosphate compounds. |
5,946 | $0 | $6 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
1,392 | $1 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
547 | $111 | $238 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 276 | $408 | $600 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
203 | $203 | $580 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
197 | $107 | $327 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
176 | $69 | $280 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
172 | $40 | $100 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
137 | $1,571 | $3,500 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
116 | $13 | $75 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
92 | $188 | $398 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
78 | $112 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
75 | $152 | $427 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
74 | $69 | $162 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
74 | $76 | $250 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
72 | $44 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
66 | $150 | $400 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
46 | $12 | $158 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
46 | $23 | $158 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
37 | $472 | $1,000 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
35 | $70 | $380 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
32 | $403 | $1,281 |
| Cardiac catheterization | 31 | $175 | $800 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.5% high complexity
66.7% medium
15.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,331
Total received (2018-2024)
Avg $476/year across 7 years
Top 29% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
141
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,908 (87.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$368 (11.1%)
Scientific / Research
Research funding and grants
$55 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$568
2023
$463
2022
$889
2021
$348
2020
$162
2019
$592
2018
$309
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$111
Penumbra, Inc.
$88
Boston Scientific Corporation
$61
Novo Nordisk Inc
$55
Amgen Inc.
$52
E.R. Squibb & Sons, L.L.C.
$48
PFIZER INC.
$47
Janssen Pharmaceuticals, Inc
$26
Baxter Healthcare
$26
Bayer Healthcare Pharmaceuticals Inc.
$20
Abbott Laboratories
$18
BIOTRONIK INC.
$15
Top 3 companies account for 45.7% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$464
Novartis Pharmaceuticals Corporation
$281
Boehringer Ingelheim Pharmaceuticals, Inc.
$269
Boston Scientific Corporation
$256
Janssen Pharmaceuticals, Inc
$197
Medtronic Vascular, Inc.
$196
PFIZER INC.
$188
Abbott Laboratories
$169
AstraZeneca Pharmaceuticals LP
$156
ABIOMED
$147
Merck Sharp & Dohme LLC
$134
Amgen Inc.
$129
Novo Nordisk Inc
$125
Edwards Lifesciences Corporation
$106
Penumbra, Inc.
$88
Bardy Diagnostics, Inc.
$82
E.R. Squibb & Sons, L.L.C.
$72
Gilead Sciences, Inc.
$64
Baxter Healthcare
$61
NOVARTIS PHARMACEUTICALS CORPORATION
$53
Regeneron Pharmaceuticals, Inc.
$33
Philips Electronics North America Corporation
$24
Bayer Healthcare Pharmaceuticals Inc.
$20
BIOTRONIK INC.
$15
Top 3 companies account for 30.4% of all-time payments
Associated products mentioned in payments ›
(5027) Intact Vascular Und · AMPLATZER AMULET · Acticor 7 VR-T DX · BRILINTA · CAMZYOS · Carnation Ambulatory Monitor · Confirm Rx · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · GENERAL - ATHERECTOMY · Hillrom - Carnation Ambulatory Monitor · Impella · JARDIANCE · Kerendia · LEQVIO · MICRA · MITRACLIP · Micra · Mitra Clip system · Ozempic · PRADAXA · Penumbra System · ROTAPRO · Repatha · Resolute · Rybelsus · VERQUVO · WATCHMAN Access System · WATCHMAN FLX · Wolverine Coronary Cutting Balloon · XARELTO · XIENCE SIERRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
443
Per 100K population
23.3
County median income
$159,674
Nearest hospital
REGIONAL MEDICAL CENTER OF SAN JOSE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Siddiqui is a mixed practice specialist, with above-average Medicare volume (top 9% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Siddiqui experienced with adenosine injection, 1 mg?
Based on Medicare claims data, Dr. Siddiqui performed 5,946 adenosine injection, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Siddiqui receive payments from pharmaceutical companies?
Yes. Dr. Siddiqui received a total of $3,331 from 24 companies across 141 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Siddiqui's costs compare to other opticians in San Jose?
Dr. Siddiqui's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Siddiqui) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in San Jose
Browse opticians in San Jose ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology